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Incidence and Prevalence for A Triply Censored Data 
 
Hilmi F. Kittani 
The Hashemite University, 
Jordan 
 
 
The model introduced for the natural history of a progressive disease has four disease states which are 
expressed as a joint distribution of three survival random variables. Covariates are included in the model 
using Cox’s proportional hazards model with necessary assumptions needed. Effects of the covariates are 
estimated and tested. Formulas for incidence in the preclinical, clinical and death states are obtained, and 
prevalence formulas are obtained for the preclinical and clinical states. Estimates of the sojourn times in 
the preclinical and clinical states are obtained. 
 
Key words: Progressive disease model, prevalence, incidence, trivariate hazard function, censored data, 
proportional hazards model, sojourn times, chronic habitué. 
 
 
Introduction 
Louis, et al. (1978) introduced a natural history 
model for a progressive disease in a set of three 
articles: Albert, Gertman and Louis (1978), 
Albert, Gertman, Louis and Liu(1978) and 
Louis, Albert and Heghinian (1978). This model 
was extended by Kittani (1995a). Clayton (1978) 
also developed a model for association for the 
bivariate case and Oakes (1982) made inferences 
about the association parameter in Clayton’s 
model. Clayton and Cuzick (1985) introduced 
the bivariate survival function for two failure 
times and made inferences about the association 
parameter, γ. Kittani (1995a, 1996, 1997, 1997-
1998) considered the model for the bivariate 
case – that is, a case with two failure times (X, 
T) – by including covariates and by using Cox’s 
proportional hazards model. 
The motivation for this research lies in 
the fact that it is necessary to identify a three 
dimensional survival function for three failure 
times (X, Y, D) with four disease states (disease 
free state, preclinical state, clinical state and 
death state). In the model, X is the age upon 
entering the preclinical state (tumor onset or first 
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heart attack), T is the age when entering the 
clinical state (symptoms first appear or second 
heart attack) and D is the age upon entering the 
death state (dying of cancer or acute myocardial 
infarction). Kittani (2010) considered estimating 
the parameters using nonparametric approach for 
a triply censored data. 
 
Background and Assumptions 
As in the Louis, et al. (1978) model, it is 
assumed that fXYZ(x,y,z,a) is continuous – that is, 
X = Y = Z = ∞ is not allowed – and Y and Z are 
termed the sojourn times in the preclinical and 
clinical states respectively. The model proposed 
by Louis, et al. (1978) makes the assumption of 
no cohort effect, meaning that the distribution of 
the random variables (X, Y, Z) is independent of 
the age distribution A, or 
 
fXYZA(x, y, z, a) = fXYZ(x, y, z) × fA(a) 
 
and 
fXYA(x, y, a) = fXY(x, y) × fA(a) 
 
where fXYZ(x, y, z) is the joint pdf of (X, Y, Z) , 
fXY(x,y) is the joint pdf of X, Y and fA(a) is the 
pdf of A( the age distribution of the subject 
population). In addition, a subject is a chronic 
habitué of the PCS if, for that subject, X < ∞, Y 
= ∞, for example, subject never leaves PCS. 
According to the model, there will be no chronic 
habitués of the PCS or CS because, if a subject 
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lives long enough, then he/she will progress to 
the next state eventually (Louis et al., 1978). 
The X, Y and Z axes are partitioned into 
I, J and K intervals according to Chiang, et al. 
(1989) and Hollford (1976); they assumed 
constant baseline hazards in each subinterval, 
λ1i(x) = μ1i, x ε Ii, λ2j (y) = μ2j , y ε Ij and λ3k (z) 
= μ3k , z ε Ik in the ith, jth and kth intervals 
respectively. The hazard functions for the nth 
individual whose (X, Y, Z) values fall in the 
cube IixIjxIk are modeled by assuming Cox’s 
(1972) proportional hazards model and holds for 
each X, Y and Z in each respective Ii, Ij and Ik 
interval. 
Assuming α, β and η (regression 
parameters) for the covariate ω (p-dimensional) 
are constant (the same) for all intervals to be 
estimated. The hazard functions λ1, λ2 and λ3 in 
the Ith, Jth and Kth intervals for nth individual 
whose observed (X, Y, Z) value is (Xn, Yn, Zn) 
will be defined as 
 
'
n(x ) e , x I1i n 1i n i
(a , a ], (y )i i 1 2 j n
'
ne ,2 j
α ω
λ = μ ∈
= λ
+
β ω
= μ
 
and 
y I (b , b ], (z )n j j j 1 3k n
'
ne , z I3k n k
(c ,c ].k k 1
∈ = λ
+
η ω
= μ ∈
=
+
 
 
Where μ1i, μ2j and μ3k are baseline hazard 
functions associated with X, Y and Z 
respectively. Assuming α, β and η are constant 
(the same) regression parameters for the 
covariate ω for all intervals and to be estimated 
along with the association parameter γ. 
The joint survival function for the three 
non-negative random variables (X, Y, Z) given 
by Kittani (1995b) is: 
 
γγγγ
1-)()()( ]2[z),F(x, 321 −++= ΛΛΛ zyx eeey . 
(2.1) 
 
Where γ > 0, x > 0, y> 0, z > 0, and Λ1, Λ2, Λ3 
are the cumulative hazard functions associated 
with X, Y and Z respectively. For example, to 
compute Λ1i(x), which is the cumulative hazard 
function for the nth individual whose x value falls 
in the ith interval (assuming a constant hazard 
over each interval) is as follows: 
 
kx
n 1
0
r 1 r n i
(x ) (u)du1i
i 1 '
(a a ) (x a ) e1r 1ir 1
+
Λ = λ
−  α ω
= μ − +μ −  = 

(2.2) 
 
where Λ2j(yn) and Λ3k(zn) are defined in a similar 
way. Thus, the joint density function (X, Y, Z) is 
 
1 32
1 2
3
3)[ ( x ) ( y ) ( z )]
y
( 1)( 2) (x ) (y)
(z) e U
1(-
f(x, ,z)
−γ Λ +Λ +Λ γ
=
γ + γ + λ λ
λ
    
 
(2.3) 
 
where γ > 0, x > 0, y > 0, z > 0, and λ1, λ2 and λ3 
are base line hazard functions associated with X, 
Y and Z respectively as 
 
31 2 (z)(x) (y)U e e e 2.γΛγΛ γΛ= + + −  
 
Kittani (1996) derived the likelihood function 
for the uncensored and censored cases in order 
to estimate the regression parameters by 
maximizing the likelihood function, that is, the 
nth individual that generates data vector wn, and 
L(wn) is the likelihood function contribution for 
the nth individual as: 
 
.1 2 N
N
L(w ,w ,...,w ) L(w )nn 1
= ∏
=
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This likelihood function is maximized with 
respect to the unknown parameter vector; θ = (γ, 
α, β, η, μ1, μ2, μ3) with dimension (3p + I + J+ 
K+1 ) where p is the number of covariates. 
To apply the Kittani (1995b) formula in 
the likelihood function it is first modeled for (X, 
Y, Z), then the transformations X = X, T = X + 
Y and D = X + Y + Z are performed to obtain 
the joint density function g(x, t, d) of (X, T, D) 
as: 
 
.
g(x,t,d) f(x,t-x,d-t)
(γ 1)(γ 2)λ (x)λ (t x)λ (d t)1 2 3
=
= + + − −
 
 
Λ (x) Λ (t x)1 2 γΛ (x) γΛ (t x)γ 1 2[e eΛ (d t )3e 1(- 3)γΛ (d t) γ3e 2]
+ − 
−  
+ + −     
−
− + − 
 
(2.4) 
 
Preclinical, Clinical and Death Incidence 
According to Louis, et al. (1978) under 
the assumption of no cohort effect, that is, (X, Y, 
Z) is independent of A, assuming 
(a)f)(I XPC =a , then preclinical incidence 
among those aged A is defined in terms of this 
model as: 
 
1iΛ (a)
PC X 1i
I 'α ωI (a) f (a) μ  e e ,
i 1
a Ii
−
= = 
=
∈
  (3.1) 
 
where fX is the marginal density of X. In order to 
define the overall preclinical incidence, IPC in 
terms of this model, the distribution of A must 
be defined. It is assumed throughout this article 
that if A is uniformly distributed over an interval 
I as 
f (a) 1 / Id ,A i
a Ii
=
∈
                (3.2) 
 
where I is the number of intervals on the x-axis 
and di is the length of interval i, then the overall 
preclinical incidence in terms of this model is 
 
0
.
.
I f (x). f (x)dxPC X A
I - Λ (x)'1 α 1iμ e .e dx1iI di 1 Ii i
I -Λ (a ) - Λ (a )1 1i i 1i i 1e e
I di 1 i
∞
= 
ω
=  
=
 +
= −   
=  
 
(3.3) 
 
Similarly, if there is no cohort effect, then the 
clinical incidence among those aged A is defined 
in terms of this model as 
 
' '
1i 2j
1(- 2)γ[Λ (x) Λ (a x)](α β ) γ
a
I (a) f (a) f(x,a-x)dx CL T
0
a
(γ 1)μ μ1i 2j
0
  e e U dx
−
+ −+ ω
= = 
= +  
 
Where 1)()( 21 −−Λ+Λ= xaexeU ji γγ  and fT is 
the marginal density of T = X + Y. This integral 
cannot be obtained in a closed form and should 
be evaluated numerically. The overall clinical 
incidence in terms of this model is 
 
I f (t) f (t)dtCL T A
0
t
f(x,t x)dx f (t)dtA0 0
tJ 1 f(x,t x)dx dt
Jdj 1 J 0j j
∞
= 
∞  = −   
    = −    
=    
 
(3.5) 
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where J is the number of intervals on the y-axis, 
dj is the length of interval j and 
 
f(x,t x)
γ(Λ (x) Λ (a x))' '(α β ) 1i 2j(γ 1) μ μ e e1i 2j
1
(- 2)γΛ (a x)γ(Λ (x) γ2j1ie e 1
− =
+ −
+ ω
+
−
−
+ −
            
 
The above integral cannot be obtained in a 
closed form and should be evaluated 
numerically. Equations (3.1) – (3.5) are similar 
to those given by Kittani (1997). 
Similarly, if there is no cohort effect, 
then death incidence among those aged A is 
defined in terms of this model as 
 
 
a
0
dt
t
0
dxt)-a,x-tx,(f(a)Df(a)DII  



==  
(3.6) 
 
This integral cannot be obtained in closed form 
and should be evaluated numerically. The 
overall death incidence in terms of this model is 
 
a
0
a
0
k
I f (t) f (t)dtDI D A
0
t
f(x,t x ,a-t)dx f (t)dt daA
0 0
tK 1 f(x,t x ,a-t)dx dt
Kdk 1 I 0k
∞
= 
∞     = −     
    = −    
=   


 
(3.7) 
 
where K is the number of intervals on the z-axis 
and dk is the length of interval. 
 
Preclinical and Clinical Prevalence 
According to Louis, et al. (1978) under 
the assumption of no cohort effect, (X, Y, Z) is 
independent of A, and the assumption of no 
chronic habitués of the PCS, then preclinical 
prevalence among those aged a is 
 
 
a
Φ (a) f (x,y)dy  dx,PC XY
0 a x
∞  =   
− 
 
(4.1) 
 
then preclinical prevalence among those aged a 
is defined in terms of this model as 
 
( )2j1i 1(- 1)γΛ (a-x)γΛ (x) γ
Φ (a)PC
a γ Λ (x)'α 1iμ e e1i
0
  e e 1 dx.
−
=
ω
+ −
(4.2) 
 
The integral cannot be obtained in a closed form 
and should be evaluated numerically. 
The overall preclinical prevalence 
according to Louis, et al. (1978) is 
 
Φ Φ (a ) f (a ) d aP C P C A0
∞
=           (4.3) 
 
and, under the assumption of no cohort effect 
and no chronic habitué s of the PCS, the overall 
preclinical prevalence is defined in terms of this 
model as 
 
( ) ]' 2j1i 1i
i
i
1a (- 1)γΛ (a-x)γΛ (x) γΛ (x)α γ
1i
J 0
Φ Φ (a)f (a)da
PC PC A
0
M 1 Φ (a)da
PCMdi 1 Ji i
M
i 1
1
Md
   μ e e e e 1 dx da−ω
∞
= 
=  
=
= 
=
     

 
+ −    
(4.4) 
 
The integral cannot be obtained in a closed form 
and should be evaluated numerically. Thus, the 
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clinical prevalence among those aged a in terms 
of this model is 
 
CS
aΦ (a) f (x,y,z)dz dy dxX0 a x d-a
∞ ∞
=   
−
 
(4.5) 
 
where f(x, y, z) is given by 
 
1 32
1 2 3
3)[ (x) (y) (z)]( 1)( 2) (x) (y) (z)e U
y
1(-
f(x, ,z)
−γ Λ +Λ +Λ γγ + γ + λ λ λ=
(4.6) 
where 
 
2 j 3k1i
(y) (z)(x)U [e e e 2].
γ Λ γ Λγ Λ
= + + −  
 
Therefore the overall clinical prevalence in 
terms of this model is 
 
Φ Φ (a) f (a)daCS CS A
0
a
f (x,y,z)dz dy dxXYZ0 0 a x d-a
aK 1 f (x,y,z)dz dy dx daXYZKdk 1 I 0 a x d-ak k
∞
= 
∞ ∞ ∞
=    
−
 
∞ ∞   =       
=
−   
(4.7) 
 
where f(x,y,z) is given by equation (4.6); the 
integral cannot be obtained in a closed form and 
should be evaluated numerically. 
 
Estimation of the Sojourn Times in the 
Preclinical and Clinical States 
Louis, et al. (1978) defined the mean 
duration of a disease in the preclinical state as 
 
.
Φ (a)daPC0E(Y| X )
I (a)daPC0
∞

< ∞ =
∞

      (5.1) 
 
However, according to this model, no cohort 
effect and no chronic habitué s of the PCS are 
assumed, thus, the quantity E[Y|X < ∞] will be 
E(Y) because P[X < ∞] is 1. Therefore, 
substituting for IPC(a) and ΦPC(a) in the above 
formula results in 
 
E (Y)
1
(- 1)a γ Λ (x)'N γα 1 iμ e e U da1ij 1 I 0j
Λ (a ) Λ (a )M 1i i 1 i i 1e e
i 1
=
−
ω  
=
+
−
=
      
    
(5.2) 
 
This integral cannot be obtained in a closed form 
and should be evaluated numerically. 
Defining the mean duration of the 
disease in the clinical state as 
 

∞

∞
=∞<
0
da(a)
CS
I
da(a)
0
CS
Φ
)Y|E(Z              (5.3) 
 
and, assuming no cohort effect and no chronic 
habitué s of the CS, the quantity E[Z| Y < ∞ ] 
will be E(Z), because P[Y < ∞] is 1. Thus, 
substituting for ICS(a) and ΦCS(a) in the above 
formula results in 
 
E( Z )
a
f (x,y,z)dz dy dx da
XYZ
0 0 a x d-a
1
(- 2)γ(Λ (x) Λ (a x))' 'a (α β ) 1i 2j γ(γ 1)μ μ e e U dx da
1i 2j
0 0
=
∞ ∞ ∞
   
−
−+ −∞ + ω
+ 
               
     
(5.4) 
 
where f(x, y, z) is given by equation (4.6). The 
integrals cannot be obtained in a closed form 
and should be evaluated numerically. 
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Asymptotic Distributions of the Epidemiological 
Measures 
In order to make inferences about the 
epidemiological measures obtained, it is 
necessary to find their distributions; the Delta 
Method (Bishop, et al., 1975) is applied to 
determine means and variances. The parameter 
vector to be estimated is θ = (γ, α, β, η, μ1, μ2, 
μ3) with dimension (3p + M+ N+ K+1 ) where p 
is the number of covariates, dim( μ1) = M, dim( 
μ2 ) = N, dim( μ3) = K and dim( α ) = dim( β ) = 
dim( η ) = p. Because θˆ  is the MLE for θ and, 
from the properties of the MLE’s, θˆ  is 
approximately normal with mean θ and the 
covariance matrix I-1[ θ ] is the inverted 
covariance matrix of θ obtained from 
maximizing the log likelihood function for the 
censored case. 
If g( θˆ ) is any function of θˆ , the 
approximate distribution of g( θˆ ) may be found 
by applying the Delta Method as 
 
'ˆ N [ [ ] .-1
g ( ) g ( )
g ( ) g ( ) , ] [ I( )]
∂ θ ∂ θθ ≈ θ θ
∂ θ ∂ θ
   
(6.1) 
where 
 
1 2 υ
g ( θ) g ( θ) g ( θ) g ( θ), ,... , ,θ θ θ θ
dim( θ) υ 3p M N K 1
 ∂ ∂ ∂ ∂
= ∂ ∂ ∂ ∂ 
= = + + + +
 
 
and the estimated variance of g( θˆ ) is 
 
θθθ
θθ
θ
θ
ˆ
'1- ]
) (g
[)]I([]
) (g
[
=



∂
∂
∂
∂ . 
 
As an example, the formulas for the 
derivatives of the preclinical incidence are 
derived as follows. The estimate of preclinical 
incidence among those aged a 
 
M ' (a)1i(a) (a) e e , a I1i ii 1
g I  PCθ
Λα ω
= = μ ∈
=
(6.2) 
ˆ
ˆM ' (a)ˆ 1iˆ ˆ(a) (a) e e , a I1i ii 1
g I  PCθ
Λα ω
= = μ ∈
=
(6.3)
 
where 
 
r 1 r i
i 1 'ˆˆ ˆ ˆ(a) (a a ) (a a ) e1i 1r 1ir 1
+
−  αωΛ = μ − +μ −  = 
 
 
Differentiating g with respect to θ, results in 
 
,0θ) (gθ) (gθ) (g
2
=
∂
∂
=
∂
∂
=
∂
∂
rm μβγ
     (6.4) 
 
and 
 
m
M ' (a)1iz e e (1 (a)) , a I1i 1i ii 1
g  
−Λ∂ α ω
= μ −Λ ∈∂α
=
(6.5) 
 
1s
s
s 1 s
M (a)' '1se e [1 (a a )e ], s i,a I1s is 1
'M (a)2 1ie e (a a ), s i, a I1i ii 1
0 , s i, a Ii
g
 
  
  
+
∂
=
∂μ
−Λ αω αω
−μ − = ∈ =
−Λ αω
− μ − < ∈ = > ∈
(6.6) 
 
To test the effect of the covariates on morbidity 
and mortality (getting into the PCS, CS and DS): 
 
H0 : α = 0 vs. H1 : α ≠ 0, 
H0 : β = 0 vs. H1 : β ≠ 0,  
and 
H0 : η = 0 vs. H1 : η ≠ 0.             (6.7) 
 
then the standard errors of the estimates are 
obtained from I-1[ θ ] which is the inverted 
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Hessian matrix obtained by numerical 
integration from special software, such as IMSL 
routines. From the properties of the MLE 
estimates, under H0: θi = 0, iθˆ  is approximately 
normal with mean zero and standard error 
SE(θi). The test statistic 
 
 ) SE( i
i
i
Z
θ
θ
θ = .                    (6.8) 
 
is used to test the previous hypotheses and 
confidence intervals for θi can be obtained. 
The estimate of the overall preclinical 
incidence 
 
1i 1i i 1
g ( θ) IPC
M - (a )1 - (a )ie e
M di 1 i
+
=
Λ Λ
= −   
=  
(6.9) 
is 
 
ˆ ˆ
ˆ ˆ
g( θ ) IPC
M -Λ (a ) -Λ (a )1 1i i 1i i 1e e
M di 1 i
=
 
+ = −  
=  
(6.10) 
 
Differentiating g with respect to θ, results in 
 
,0θ) (gθ) (gθ) (g
2
=
∂
∂
=
∂
∂
=
∂
∂
rm μβγ
 
(6.11) 
and 
 
m
(a )1i i 1(a )eM ' 1i i 1z e
(a )i 1 1i i(a )e1i i
g
1
M di
∂
∂α
−Λ +Λ +α ω  = 
−Λ =  −Λ 
(6.12) 
 
i 1
1i 1i
1s
M ' (a )1 1ie e s i,a IiMi 1
'M 1 e , s i, a IiMi 1
0 , s i, a Ii
i 1 i
    
g - (a ) - (a )e e    
 
+
+
−Λ αω
= ∈ =∂  Λ Λαω 
= − < ∈  ∂μ   = > ∈
(6.13) 
 
The covariance matrix for IPC is 
 
'1- ]
) (g
[)]I([]
) (g
[
θ
θθ
θ
θ
∂
∂
∂
∂  
 
where I-1[ θ ] the inverted covariance matrix of θ 
obtained from maximizing the log likelihood 
function for the censored case. 
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